Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Nov;123(11):1570-4.
doi: 10.1001/archopht.123.11.1570.

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

Frederick L Ferris  1 , Matthew D Davis, Traci E Clemons, Li-Yin Lee, Emily Y Chew, Anne S Lindblad, Roy C Milton, Susan B Bressler, Ronald Klein; Age-Related Eye Disease Study (AREDS) Research Group
Affiliations

A simplified severity scale for age-related macular degeneration: AREDS Report No. 18

Frederick L Ferris et al. Arch Ophthalmol. 2005 Nov.

Abstract

Objective: To develop a simplified clinical scale defining risk categories for development of advanced age-related macular degeneration (AMD).

Methods: Following development of a detailed scale for individual eyes based on gradings of fundus photographs in the Age-Related Eye Disease Study, rates of progression to advanced AMD were assessed in cross-tabulations of presence or absence in each eye of 2 easily identified retinal abnormalities, drusen and pigment abnormalities. Large drusen and any pigment changes were particularly predictive of developing advanced AMD.

Results: The scoring system developed for patients assigns to each eye 1 risk factor for the presence of 1 or more large (> or = 125 microm, width of a large vein at disc margin) drusen and 1 risk factor for the presence of any pigment abnormality. Risk factors are summed across both eyes, yielding a 5-step scale (0-4) on which the approximate 5-year risk of developing advanced AMD in at least one eye increases in this easily remembered sequence: 0 factors, 0.5%; 1 factor, 3%; 2 factors, 12%; 3 factors, 25%; and 4 factors, 50%. For persons with no large drusen, presence of intermediate drusen in both eyes is counted as 1 risk factor.

Conclusion: This simplified scale provides convenient risk categories for development of advanced AMD that can be determined by clinical examination or by less demanding photographic procedures than used in the Age-Related Eye Disease Study.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Fundus photograph to illustrate drusen size. In the 8-o’clock meridian, about 1 disc diameter from the center of the macula, there is a large druse, slightly larger than the minimum required to meet the greater than or equal to 125 μm (width of an average large vein at the disc margin) definition. At 5:30, near the edge of the photograph, there is an intermediate druse, defined as greater than or equal to 63 μm but less than 125 μm in diameter.
Figure 2
Figure 2
Risk factor scoring for patient with large drusen and pigment abnormalities in both eyes.
Figure 3
Figure 3
Fundus photograph of an eye with 2 risk factors (large drusen and pigment abnormalities).
Figure 4
Figure 4
Risk of progression to advanced age-related macular degeneration (in at least one eye in patients with both eyes at risk) based on repeated-measures logistic repression analysis of 4710 Age-Related Eye Disease Study participants, by simplified risk score assigned at baseline.
Figure 5
Figure 5
Risk of progression to advanced age-related macular degeneration (in at least one eye in patients with both eyes at risk) based on repeated-measures logistic regression analysis of Age-Related Eye Disease Study (AREDS) participants randomized to the AREDS combined treatment group (antioxidants plus zinc [AZ]) or placebo (P), by simplified risk score assigned at baseline.
Figure 6
Figure 6
Approximate 5-year rates of progression to advanced age-related macular degeneration.
See this image and copyright information in PMC

Comment in

References

    1. The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol. 2005;123:1484–1498. - PMC - PubMed
    1. The Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: AREDS Report Number 6. Am J Ophthalmol. 2001;132:688–681. - PubMed
    1. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98:1128–1134. - PubMed
    1. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration: the International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374. - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS Report Number 12. Ophthalmology. 1991;98:823–833. - PubMed

Publication types

MeSH terms